{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:58:19Z","timestamp":1791212299587,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001136","name":"Australian and New Zealand College of Anaesthetists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001136","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001794","name":"University of Queensland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001077","name":"Royal Brisbane and Women's Hospital Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001077","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","obstetanesthesia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Obstetric Anesthesia"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ijoa.2026.104874","type":"journal-article","created":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T16:14:32Z","timestamp":1771690472000},"page":"104874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Plasma levels and postpartum breastmilk concentrations of sugammadex: a pharmacokinetic study in women undergoing general anaesthesia for caesarean delivery"],"prefix":"10.1016","volume":"66","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3969-1916","authenticated-orcid":false,"given":"A.T.","family":"Hodge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.R.","family":"Tognolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X.","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Won","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.C.","family":"Wallis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.A.","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.A.","family":"Eley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.ijoa.2026.104874_b0005","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1093\/bja\/aex171","article-title":"Using a worldwide in-app survey to explore sugammadex usage patterns: a prospective observational study","volume":"119","author":"O'Reilly-Shah","year":"2017","journal-title":"Br J Anaesth."},{"issue":"4","key":"10.1016\/j.ijoa.2026.104874_b0010","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1097\/00000542-200510000-00007","article-title":"First human exposure of Org 25969, a novel agent to reverse the action of rocuronium bromide","volume":"103","author":"Gijsenbergh","year":"2005","journal-title":"Anesthesiology."},{"issue":"3","key":"10.1016\/j.ijoa.2026.104874_b0015","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/0259-1162.123211","article-title":"Sugammadex: a revolutionary drug in neuromuscular pharmacology","volume":"7","author":"Nag","year":"2013","journal-title":"Anesth Essays Res."},{"issue":"1","key":"10.1016\/j.ijoa.2026.104874_b0020","first-page":"48","article-title":"Preliminary Indications for the use of Sugammadex after its Addition to a Formulary at a Tertiary Care Children's Hospital","volume":"23","author":"Barry","year":"2018","journal-title":"J Pediatr Pharmacol Ther."},{"key":"10.1016\/j.ijoa.2026.104874_b0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jclinane.2016.06.018","article-title":"Efficacy and safety of sugammadex compared to neostigmine for reversal of neuromuscular blockade: a meta-analysis of randomized controlled trials","volume":"35","author":"Carron","year":"2016","journal-title":"J Clin Anesth."},{"issue":"2","key":"10.1016\/j.ijoa.2026.104874_b0030","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1097\/ALN.0b013e3182065c36","article-title":"Efficacy, safety, and pharmacokinetics of sugammadex for the reversal of rocuronium-induced neuromuscular blockade in elderly patients","volume":"114","author":"McDonagh","year":"2011","journal-title":"Anesthesiology."},{"issue":"5","key":"10.1016\/j.ijoa.2026.104874_b0035","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1093\/bja\/aet586","article-title":"Efficacy, safety and pharmacokinetics of sugammadex 4 mg kg-1 for reversal of deep neuromuscular blockade in patients with severe renal impairment","volume":"114","author":"Panhuizen","year":"2015","journal-title":"Br J Anaesth"},{"issue":"5","key":"10.1016\/j.ijoa.2026.104874_b0040","first-page":"529","article-title":"Sugammadex for reversal of neuromuscular blockade in paediatric patients: a two-year single-centre retrospective study","volume":"38","author":"Simonini","year":"2019","journal-title":"Anaesth Crit Care Pain Med"},{"issue":"1","key":"10.1016\/j.ijoa.2026.104874_b0045","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/bja\/aep340","article-title":"Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study","volume":"104","author":"Staals","year":"2010","journal-title":"Br J Anaesth."},{"key":"10.1016\/j.ijoa.2026.104874_b0050","unstructured":"Australian Government. Australian Institute of Health and Welfare Health. National Core Maternity Indicators. Canberra: 2019. Available from: https:\/\/www.aihw.gov.au\/reports\/mothers-babies\/national-core-maternity-indicators\/contents\/summary (accessed January 2023)."},{"key":"10.1016\/j.ijoa.2026.104874_b0055","unstructured":"Willett A, Butwick A, Togioka B, et al. Society for Obstetric Anesthesia and Perinatology statement on sugammadex during pregnancy and lactation: April, 2019. Available from: https:\/\/www.soap.org\/assets\/docs\/SOAP_Statement_Sugammadex_During_Pregnancy_Lactation_APPROVED.pdf (accessed May 2024)."},{"issue":"3","key":"10.1016\/j.ijoa.2026.104874_b0060","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1213\/01.ane.0000244594.63318.fc","article-title":"Sugammadex: another Milestone in Clinical Neuromuscular Pharmacology","volume":"104","author":"Naguib","year":"2007","journal-title":"Anesth Analg."},{"key":"10.1016\/j.ijoa.2026.104874_b0065","unstructured":"Drugs and Lactation Database (LactMed\u00ae) [Internet]. Bethesda (MD): National Institute of Child Health and Human Development; 2006. Sugammadex. [Updated 2023 Apr 15]. Available from: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK500924\/."},{"issue":"6","key":"10.1016\/j.ijoa.2026.104874_b0070","doi-asserted-by":"crossref","first-page":"1628","DOI":"10.1213\/ANE.0000000000004305","article-title":"Sugammadex Administration in Pregnant Women and in Women of Reproductive potential: a Narrative Review","volume":"130","author":"Richardson","year":"2020","journal-title":"Anesth Analg."},{"issue":"6","key":"10.1016\/j.ijoa.2026.104874_b0075","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/j.1399-6576.2011.02431.x","article-title":"Rocuronium and sugammadex for rapid sequence induction of obstetric general anaesthesia","volume":"55","author":"Williamson","year":"2011","journal-title":"Acta Anaesthesiol Scand."},{"issue":"11","key":"10.1016\/j.ijoa.2026.104874_b0080","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1111\/anae.13260","article-title":"Obstetric Anaesthetists' Association and Difficult Airway Society guidelines for the management of difficult and failed tracheal intubation in obstetrics","volume":"70","author":"Mushambi","year":"2015","journal-title":"Anaesthesia."},{"issue":"6","key":"10.1016\/j.ijoa.2026.104874_b0085","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.bjae.2020.03.003","article-title":"General anaesthesia in obstetrics","volume":"20","author":"Delgado","year":"2020","journal-title":"BJA Educ."},{"issue":"1","key":"10.1016\/j.ijoa.2026.104874_b0090","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s40140-021-00437-6","article-title":"The Current Role of General Anesthesia for Cesarean delivery","volume":"11","author":"Ring","year":"2021","journal-title":"Curr Anesthesiol Rep."},{"issue":"5","key":"10.1016\/j.ijoa.2026.104874_b0095","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1111\/ajo.12399","article-title":"SOMANZ guidelines for the management of hypertensive disorders of pregnancy 2014","volume":"55","author":"Lowe","year":"2015","journal-title":"Aust N Z J Obstet Gynaecol."},{"issue":"1","key":"10.1016\/j.ijoa.2026.104874_b0100","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/bjaceaccp\/mkv008","article-title":"Anaesthetic implications for liver disease in pregnancy","volume":"16","author":"Griffiths","year":"2015","journal-title":"BJA Educ."},{"key":"10.1016\/j.ijoa.2026.104874_b0105","unstructured":"Bridion Summary of Product characteristics, M.S.D.B. V., Editor. 2008: Waarderwag 39, 2031 BN Haarlem, The Netherlands."},{"key":"10.1016\/j.ijoa.2026.104874_b0110","unstructured":"U.S. Department of Health and Human Services Food and Drug Administration, Centre for Drug Evaluation and Research (CDER), Bioanalytical Method Validation Guidance for Industry May 2018. Available from: https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf (accessed 28th October 2025)."},{"key":"10.1016\/j.ijoa.2026.104874_b0115","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.ijoa.2017.05.002","article-title":"Intravenous dexmedetomidine for cesarean delivery and its concentration in colostrum","volume":"32","author":"Yoshimura","year":"2017","journal-title":"Int J Obstet Anesth."},{"issue":"1","key":"10.1016\/j.ijoa.2026.104874_b0120","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1097\/ALN.0b013e318190bc32","article-title":"Pharmacokinetic-pharmacodynamic model for the reversal of neuromuscular blockade by sugammadex","volume":"110","author":"Ploeger","year":"2009","journal-title":"Anesthesiology."},{"issue":"3","key":"10.1016\/j.ijoa.2026.104874_b0125","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2125.2011.04000.x","article-title":"Population pharmacokinetic-pharmacodynamic analysis for sugammadex-mediated reversal of rocuronium-induced neuromuscular blockade","volume":"72","author":"Kleijn","year":"2011","journal-title":"Br J Clin Pharmacol."},{"issue":"5","key":"10.1016\/j.ijoa.2026.104874_b0130","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1023\/A:1012299115260","article-title":"Ways to fit a PK model with some data below the quantification limit","volume":"28","author":"Beal","year":"2001","journal-title":"J Pharmacokinet Pharmacodyn."},{"issue":"7","key":"10.1016\/j.ijoa.2026.104874_b0135","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1053\/j.semperi.2015.08.003","article-title":"Pharmacokinetics of drugs in pregnancy","volume":"39","author":"Feghali","year":"2015","journal-title":"Semin Perinatol."},{"issue":"9","key":"10.1016\/j.ijoa.2026.104874_b0140","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1007\/s11095-013-1085-5","article-title":"Contribution of protein binding, lipid partitioning, and asymmetrical transport to drug transfer into milk in mouse versus human","volume":"30","author":"Ito","year":"2013","journal-title":"Pharm Res."},{"issue":"3","key":"10.1016\/j.ijoa.2026.104874_b0145","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1097\/01.grf.0000135653.56778.3f","article-title":"Maternal medications during breastfeeding","volume":"47","author":"Hale","year":"2004","journal-title":"Clin Obstet Gynecol."},{"key":"10.1016\/j.ijoa.2026.104874_b0150","unstructured":"European Medicines Agency (EMA) [Internet]. The Netherlands: Annual report of the European Medicines Agency. 2008 [cited 2019 Apr 10]. Available from: https:\/\/www.ema.europa.eu\/en (accessed September 2025)."}],"container-title":["International Journal of Obstetric Anesthesia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X26000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959289X26000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:48:00Z","timestamp":1791211680000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959289X26000312"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":30,"alternative-id":["S0959289X26000312"],"URL":"https:\/\/doi.org\/10.1016\/j.ijoa.2026.104874","relation":{},"ISSN":["0959-289X"],"issn-type":[{"value":"0959-289X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Plasma levels and postpartum breastmilk concentrations of sugammadex: a pharmacokinetic study in women undergoing general anaesthesia for caesarean delivery","name":"articletitle","label":"Article Title"},{"value":"International Journal of Obstetric Anesthesia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijoa.2026.104874","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104874"}}